The planned sites in Livonia, Las Vegas, and San Antonio would expand a partnership that places clinical research and health screenings inside Walmart stores.
|Articles|April 16, 2020
People and Business News
The latest business and people happenings, and COVID-19 response, from around the industry.
Advertisement
People News
PRISYM ID has made changes to its senior leadership team. Life sciences and technology veteran Richard Adams has joined as Chief Executive Officer, and Lauren Patterson has been appointed Chief Financial Officer.
Advarra announced the appointment of Gadi Saarony as Chief Executive Officer.
MMS Holdings Inc. announced the addition of Kelly Vaillant as Director, Global Transparency Strategy and Compliance.
Business News
SGS is supporting ZNA Stuivenberg Hospital, Antwerp in its fight against the COVID-19 pandemic by offering the use of its Clinical Pharmacology Unit, within the hospital, equipped with 88 beds. SGS has also donated Personal Protective Equipment, including 1,100 masks and 21,000 gloves.
WCG is providing access to a web resource, WCG COVID-19 Patient Insights Resource Center, dedicated to representing the voice, perspective, and needs of patients and study participants in clinical trials during the COVID-19 pandemic.
BioIVT announced the opening of its new blood donor center on the Tufts University campus in Medford, MA to support academic and pharmaceutical researchers involved in COVID-19, cell and gene therapy research.
Sharp Clinical has confirmed that it is involved in supporting six clinical trials related to COVID-19.
Syneos Health, supported by the Association of Clinical Research Organizations, has announced a volunteer program to enable clinically qualified employees to address the UK government’s call for volunteers to support COVID-19 testing.
CROMSOURCE announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company.
Recognition
PPD, Inc. has been named by IDG’s CIO as a 2020 CIO 100 Awards honoree.
TrialScope’s “Real Patient Stories: The Trials of Finding Clinical Trials,” has won a Silver award in the WEGO Health Patient-Choice Awards for Most Authentic Use of Patients in a Marketing Campaign.
Advertisement
Related to this article
In this video interview, Kent Thoelke, CEO of Paradigm Health, calls for safe harbor protections, CMS reimbursement safeguards, and funding mechanisms modeled on EHR meaningful use to help community and rural institutions participate in research on par with academic centers.
In today’s ACT Brief, we examine why community and rural patients lack access to research as a care option, what makes AI assistants trustworthy in regulated trials, and how FDA draft guidance could let gene editing therapies cover patient-specific variants.
In this Q&A, E.K. Koh, chief product officer at Suvoda, discusses what separates a trustworthy AI assistant from one that adds risk, why curated clinical knowledge matters more than general-purpose flexibility, and what safeguards must be in place when assistants move from answering questions to taking actions in clinical trial systems.
In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patients in community and rural settings too often lack access to clinical research as a care option, and how closing that gap could improve outcomes and lower long-term costs.
In today’s ACT Brief, we examine why anti-kickback guidance and EHR-integrated trial matching must work together in community settings, why real-time trials depend on mature risk-based quality management, and how pharma is applying digital clones to predict outcomes.
The FDA’s RTCT initiative transmits predefined, clinically meaningful signals to regulators during active trials, so its value depends entirely on the maturity of sponsors’ upstream RBQM signal intelligence, KRIs, QTLs, and root-cause context, rather than on data speed.
In this video interview, Kent Thoelke, CEO of Paradigm Health, outlines why anti-kickback guidance and modern EHR-integrated trial matching technology must work in tandem to reach representative patient populations at the community level.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Building AI Assistants Clinical Trial Teams Can Trust: Q&A with E.K. Koh, Suvoda
2
What Needs to Happen Beyond the Clinical Trial Modernization Act
3
Walmart and Care Access Plan Three More Clinical Trial Centers in Michigan, Nevada, and Texas
4
Closing the Medical Writing Capacity Gap: Why Training Beats Technology
5